Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 74 citing Chen: Intravitreal triamcinolone acetonide for ischaemic macular oedema caused by branch.... (0.15 sec) 

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and …


JB Jonas - Acta Ophthalmologica Scandinavica, 2005 - duanesolution.com
Cited by 89 - Related articles - BL Direct - All 5 versions

Intravitreal triamcinolone injection for treatment of macular edema secondary to …


O ÇEkİÇ, S Chang, JJ TSENG, GR BARILE, LV DEL … - Retina, 2005 - journals.lww.com
Methods: The authors performed a retrospective chart review of 13 eyes of 13 patients (mean age 68
years) who underwent intravitreal injections with 4 mg triamcinolone acetonide for macular edema due
to BRVO. Six eyes received a single ...
Cited by 64 - Related articles - BL Direct - All 4 versions

Intravitreal triamcinolone acetonide in patients with macular oedema due to central …


K Krepler, E Ergun, S Sacu, S Richter-Muksch … - Acta Ophthalmologica …, 2005 - pt.wkhealth.com
Methods: In a prospective case series, 13 patients with macular oedema due to non-ischaemic CRVO
received an intravitreal injection of 4 mg triamcinolone acetonide. Examination included assessment
of best corrected visual acuity ...
Cited by 55 - Related articles - All 8 versions

Intravitreal triamcinolone treatment for macular edema associated with central …


O ÇEkiÇ, S Chang, JJ TSENG, GR BARILE, H … - Retina, 2005 - journals.lww.com
RETINA. Wolters Kluwer Health Logo. All Issues. ...
Cited by 46 - Related articles - BL Direct - All 4 versions

Intravitreal triamcinolone acetonide: a change in a paradigm


JB Jonas - Ophthalmic Res, 2006 - content.karger.com
Background: Based on experimental studies and clinical observations by Robert Machemer, Gholam
Peyman and others, the vitreous cavity has increasingly been used as a reservoir of drugs for the
direct treatment of intraocular ...
Cited by 46 - Related articles - BL Direct - All 5 versions

Cataract formation and other complications of intravitreal triamcinolone for macular …


JT Thompson - American journal of ophthalmology, 2006 - Elsevier
The mean visual acuity improved from 20/125 to −1 to 20/100 + 2 by one to two months after
injection (P < .001) and was 20/100 at the final examination (P = .006) at a mean of 1.2 years after
injection. Complications included a ...
Cited by 43 - Related articles - All 21 versions

Intravitreal triamcinolone for the treatment of ischemic macular edema associated …


SDM Chen, V Sundaram, J Lochhead, CK Patel - American journal of …, 2006 - Elsevier
The mean duration of BRVO before treatment was 14 months. All patients were followed for a minimum
of nine months, and 12 patients completed 12 months follow-up. The mean logarithm of the minimum
angle of resolution (logMAR) VA ...
Cited by 45 - Related articles - All 17 versions

Intravitreal versus retrobulbar injections of triamcinolone for macular edema …


K Hayashi, H Hayashi - American journal of ophthalmology, 2005 - Elsevier
Sixty eyes of 60 patients who had macular edema associated with branch retinal vein occlusion were
randomly assigned to receive a single intravitreal injection (4 mg) or repeated retrobulbar
injections (40 mg, three times) of ...
Cited by 41 - Related articles - All 10 versions

One-year safety and efficacy of intravitreal triamcinolone acetonide for the …


NZ GREGORI, PJ ROSENFELD, CA PULIAFITO, HW … - Retina, 2006 - journals.lww.com
NINEL Z. GREGORI, MD,* PHILIP J. ROSENFELD, MD, PHD,* CARMEN A. PULIAFITO, MD, MBA,* HARRY W. FLYNN
JR, MD,* JI EUN LEE, MD,* ELIAS C. MAVROFRIDES, MD,* WILLIAM E. SMIDDY, MD,* TIMOTHY G. MURRAY, MD,*
AUDINA M. BERROCAL, MD,* INGRID U. ...
Cited by 36 - Related articles - BL Direct - All 3 versions

Intravitreal triamcinalone acetonide for refractory uveitic cystoid macular oedema: …


RI Angunawela, CJ Heatley, TH Williamson, … - Acta Ophthalmologica …, 2005 - pt.wkhealth.com
Results: There was complete resolution of CMO in all patients. Nine patients had improvement in
acuity at there final follow up (mean follow up 40.5 months). Seven had improved by 2 lines (58%).
In 3 patients there was no visual ...
Cited by 29 - Related articles - All 4 versions


Result Page: 

1

2

3

4

5

6

7

8

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google